LIXTE Biotechnology Holdings, Inc. announced the appointment of Professor René Bernards to its Board of Directors. Professor Bernards will serve as an independent director. Professor Bernards is a leader in the field of molecular carcinogenesis, working at the Netherlands Cancer Institute in Amsterdam.

His research focuses on identifying effective new drug combinations, new drug targets, and mechanisms of resistance to anti-cancer drugs. He has also co-founded four biotechnology companies to bring his scientific discoveries to clinical oncology practice. Professor Bernards has received many awards recognizing his excellence in cancer research.

He is a member of the Royal Netherlands Academy of Sciences, an International Honorary Member of the American Academy of Arts and Sciences and an International member of the National Academy of Sciences (USA). Additionally, he is a fellow of the American Association for Cancer Research (AACR) and received the Princess Takamatsu Memorial Lectureship at this year's AACR annual meeting.